tirzepatide fiber FDA Grants a New Indication for Obesity Management Fiber & Tirzepatide: Optimizing Digestion

GLP-1 receptor activation enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways

Thanks!!!

346,347 Moreover, animal experiments have also found that synovial inflammation in RA can be aggravated by intravenous iron

Food and Drug Administration (FDA) has approved tirzepatide for the treatment of type 2 diabetes and, more recently, for chronic weight management in people with obesity or who are overweight and have related health problems

Pediatr Res 64, 470476, 10.1203/PDR.0b013e318186e609 (2008)

Branded medications like Wegovy specifically address weight management, while Ozempic supports type 2 diabetes care